CVCDAP
CVCDAP enables cohort-level analysis of large-scale multi-omics cancer datasets from TCGA, CPTAC, and user-uploaded data to identify molecular and clinical associations.
Key Features:
- Dataset integration: Integrates multi-omics data from TCGA, CPTAC, and user-uploaded datasets for combined analysis.
- Customizable analysis toolbox: Provides configurable analytical modules for cohort-level studies.
- Virtual cohort creation: Selects patients across multiple studies based on shared molecular and clinical characteristics to form virtual cohorts.
- Multi-omics analysis: Supports genomic, transcriptomic, proteomic, and clinical analyses, including single-cohort and two-cohort comparisons.
- Reproducibility and discovery: Enables reproduction of published findings and identification of novel molecular mechanisms and potential therapeutic approaches.
Scientific Applications:
- Virtual cohort analysis: Build and analyze cohorts defined by molecular or clinical criteria to study specific cancer subgroups.
- Comparative cohort studies: Compare two cohorts to identify differential genomic, transcriptomic, or proteomic patterns.
- Validation of published results: Reproduce and validate findings reported in the literature using integrated TCGA and CPTAC data.
- Mechanism and target discovery: Identify candidate molecular mechanisms and potential therapeutic approaches from multi-omics associations.
Methodology:
Integrates multi-omics data from multiple sources into a cohesive analytical framework, enables definition of virtual cohorts based on shared molecular or clinical characteristics, and applies built-in tools ranging from descriptive statistics to comparative cohort analyses.
Topics
Details
- Tool Type:
- web application
- Added:
- 1/18/2021
- Last Updated:
- 2/18/2021
Operations
Publications
Guan X, Cai M, Du Y, Yang E, Ji J, Wu J. CVCDAP: an integrated platform for molecular and clinical analysis of cancer virtual cohorts. Nucleic Acids Research. 2020;48(W1):W463-W471. doi:10.1093/nar/gkaa423. PMID:32449936. PMCID:PMC7439093.
DOI: 10.1093/NAR/GKAA423
PMID: 32449936
PMCID: PMC7439093
Funding: - Peking University: PKU2018LCXQ015
- Peking University Cancer Hospital: 16-01
- PKU-Baidu Fund: 2019BD012
- Michigan Medicine-PKUHSC: BMU2019JI010
- Beijing Municipal Bureau of Health: 2019-1